# Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

> **NCT01491412** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 503 (actual)

## Conditions studied

- Acute Psychotic Episode
- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01491412
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** —
- **Final completion:** 2012-05
- **Target enrollment:** 503 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01491412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01491412, "Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01491412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*